Setting up an Oral Rehydration Salt (ORS) Manufacturing Plant in India means producing one of the most important and widely used essential medicines in the country. ORS, a precise mix of glucose and salts dissolved in water, treats dehydration from diarrhoea, heat stress, and illness, and is a cornerstone of child health programmes. India's hot climate, large paediatric population, and public health focus on diarrhoea management keep demand steady through the year, with seasonal peaks in summer and the monsoon. A recent regulatory change has also sharpened the market: only products that follow the WHO formula may now use the term "ORS" on their labels.
The Oral Rehydration Salt (ORS) Manufacturing Plant Cost depends on capacity, formats, and the level of automation. A powder sachet unit producing 50 to 100 million sachets a year typically needs INR 8 crore to INR 25 crore, while a larger facility that adds ready-to-drink liquid ORS in tetra packs or bottles can require INR 40 crore to INR 80 crore. Glucose, salts, and laminated sachet material form the bulk of operating cost, so efficient procurement and high-speed packing drive margins. At healthy utilisation, a well-run plant can earn a net profit margin of 12 to 20% and an IRR of 18 to 25%, with payback typically within 3 to 5 years.
This guide is written for pharmaceutical companies, contract manufacturers, and investors exploring how to start an Oral Rehydration Salt (ORS) manufacturing plant in India. It explains product formats, demand drivers, the blending and packing process, machinery and raw materials, location and infrastructure, a detailed cost and returns breakdown, the drug and food regulations involved, and how a DPR turns all of this into a bankable plan.
| Key Facts | Details |
|---|---|
| WHO Low-Osmolarity ORS | 245 mOsm Per Litre of solution |
| Main Formats | Powder sachets and ready-to-drink liquid |
| Indicative Investment (Sachet Plant) | INR 8–25 Crore |
| Typical Payback Period | 3–5 Years |
The snapshot reflects a product with steady, essential demand and a well-defined formula. Revenue comes from retail pharmacy sales of branded ORS, government and NGO procurement for public health programmes, institutional supply to hospitals, and exports to other countries with high diarrhoeal disease burdens. The investment range reflects the choice between a focused powder sachet line and a larger plant that also produces ready-to-drink ORS.
Indicative Project Cost in India (2026)
| Parameter | Value |
|---|---|
| Product Range | WHO-ORS sachets, flavoured ORS, ready-to-drink ORS, ORS + zinc kits |
| Total Project Investment | INR 8 – 25 Crore (sachets); INR 40 – 80 Crore (with RTD) |
| Payback Period | 3 – 5 Years |
| Net Profit Margin | 12 – 20% |
| IRR | 18 – 25% |
| Best Locations | Himachal Pradesh, Gujarat, Uttarakhand, Telangana, Maharashtra |
| Mandatory Approvals | Drug Manufacturing License, Revised Schedule M, SPCB, Factory License |
| Key Requirement | WHO-compliant formulation and low-humidity GMP packing |
These parameters provide a practical starting frame. Returns depend on producing exactly to the WHO and pharmacopoeial formula, controlling humidity so the powder stays free-flowing, running sachet lines at high speed, and selling through both branded retail and institutional tenders. A format-specific Oral Rehydration Salt (ORS) Feasibility Report refines these numbers for your capacity, channels, and site.
Table of Contents
Oral rehydration salts are a dry mixture of sodium chloride, potassium chloride, trisodium citrate, and glucose that, when dissolved in clean water, replaces fluids and electrolytes lost through diarrhoea and dehydration. The current WHO and UNICEF low-osmolarity formula provides, per litre of solution, 2.6 g of sodium chloride, 13.5 g of anhydrous glucose, 1.5 g of potassium chloride, and 2.9 g of trisodium citrate dihydrate, giving a total osmolarity of 245 mOsm per litre. An Oral Rehydration Salt (ORS) Manufacturing Plant weighs and blends these ingredients precisely, packs them in moisture-proof sachets or prepares them as ready-to-drink solutions, and tests every batch for composition and quality.
From a business perspective, ORS combines steady demand with relatively simple, well-understood technology. Customers include pharmacies and retail chains selling branded ORS, government health programmes and NGOs buying through tenders, hospitals and clinics, and export buyers in Asia and Africa. Pharmaceutical companies also outsource ORS to contract manufacturers, which adds another route to volume.
ORS Product Formats and Channels
Choosing which formats and channels to target is the foundational decision, because it shapes machinery, regulation, and margins:
| Format | Description | Key Property | Primary Demand |
|---|---|---|---|
| Powder Sachets | Blended powder in laminated sachets | Low cost, long shelf life | Retail, government, exports |
| Flavoured Sachets | WHO formula with flavour | Better acceptance | Paediatric retail |
| Ready-to-Drink | Sterile liquid in tetra packs or bottles | Convenience, accurate dosing | Urban retail, hospitals |
| ORS + Zinc Kits | Co-packed sachets and zinc tablets | Programme standard | Public health tenders |
This choice shapes the plant. A powder sachet facility centres on dry blending and multi-track sachet packing in low-humidity rooms, while ready-to-drink production needs water purification, mixing, sterilisation or aseptic filling, and different packaging lines. Most new entrants begin with sachets, which offer the widest market and lowest capital, and add flavoured, kit, or liquid formats as their customer base grows.
Key Growth Drivers in the Indian Market
Demand for ORS in India is supported by public health priorities, climate, and growing consumer awareness:
India-Specific Market Opportunity
| Segment | India Market Context | Manufacturing Role |
|---|---|---|
| Retail Pharmacy | Branded ORS widely prescribed | Branded sachets and RTD |
| Government Programmes | Free or low-cost distribution | Tender-compliant sachets and kits |
| Hospitals & Clinics | Institutional use | Bulk sachets and RTD |
| Contract Manufacturing | Brands outsourcing ORS | Third-party production |
| Exports | High-burden countries | WHO-GMP certified supply |
The strongest opportunity lies in combining branded or contract retail supply with institutional and export business. Public health tenders provide large, steady volumes at tight prices, while branded and flavoured products for pharmacies, along with ready-to-drink formats, earn better margins. Plants with WHO-GMP certification can also reach export and donor-funded markets.
Understanding the process helps you plan equipment, clean areas, and quality control. ORS production is technically simple but demands precise weighing, uniform blending, and strict moisture control, because glucose and salts absorb moisture and can cake or degrade if exposed. The flow below covers a powder sachet line; ready-to-drink production follows a parallel liquid process.
Step-by-Step ORS Manufacturing Process Flow
Raw materials are tested, dried where needed, sifted, and weighed to the formula. They are blended to a uniform mix, checked for content uniformity, then filled into laminated sachets on multi-track machines in a low-humidity room. Sachets are sealed, coded, inspected, cartoned, and released after testing.
| Unit Operation | Key Activity |
|---|---|
| Raw Material Receipt & Testing | Salts and glucose tested to pharmacopoeial specs |
| Drying & Conditioning | Moisture reduced where required |
| Sifting & Milling | Particle size made uniform |
| Dispensing | Ingredients weighed to WHO formula |
| Blending | Uniform mixing in V or octagonal blender |
| In-Process Testing | Content uniformity and moisture checks |
| Sachet Filling & Sealing | Low-humidity multi-track sachet packing |
| Coding & Inspection | Batch, expiry, and leak checks |
| Cartoning & Kitting | Cartons and ORS + zinc kits packed |
| QC Release & Dispatch | Finished product testing and release |
Two factors decide profitability across this flow. First, accuracy and uniformity: every sachet must deliver the correct quantities of each ingredient, so precise weighing, validated blending, and fill-weight control are essential. Second, moisture control: low relative humidity in blending and packing rooms, moisture-barrier laminates, and good sealing prevent caking and protect shelf life. For ready-to-drink ORS, water purity, sterilisation, and aseptic or hot filling become the critical controls.
The main inputs are anhydrous glucose, sodium chloride, potassium chloride, and trisodium citrate, all of pharmacopoeial grade, along with laminated sachet material and cartons. Flavours and sweeteners may be added within permitted limits for flavoured variants.
| Raw Material | Role in Process | India Sourcing | % of OpEx |
|---|---|---|---|
| Anhydrous Glucose (Dextrose) | Carbohydrate for absorption | Domestic starch processors | 15–22% |
| Sodium Chloride, Potassium Chloride | Electrolytes | Domestic pharma-grade suppliers | 5–8% |
| Trisodium Citrate Dihydrate | Buffer and electrolyte | Domestic and imported | 4–7% |
| Laminated Sachet Film | Moisture-proof packaging | Domestic flexible packaging | 15–22% |
| Cartons, Flavours & Other Packing | Secondary packaging and variants | Domestic suppliers | 6–10% |
Because the active ingredients are inexpensive commodity chemicals, packaging is a surprisingly large share of cost, especially for small sachets. Suppliers must provide pharmacopoeial-grade materials with certificates of analysis, and incoming lots are tested before use. Procurement of glucose and laminate film at stable prices, and minimising packing waste, have a direct effect on margins.
Location matters in any Oral Rehydration Salt (ORS) Manufacturing Plant Setup in India, because ORS is a regulated medicine produced in large volumes for nationwide distribution. The best sites offer access to pharmaceutical clusters, skilled GMP staff, packaging suppliers, reliable power for dehumidification, and good logistics.
Best Location for Oral Rehydration Salt (ORS) Manufacturing Plant Setup in India
| State | Why It Works | Key Advantage |
|---|---|---|
| Himachal Pradesh | Baddi pharma cluster | Large formulation ecosystem |
| Gujarat | Ahmedabad and Vadodara pharma belt | Raw materials and packaging |
| Uttarakhand | Haridwar and Dehradun clusters | Formulation units and incentives |
| Telangana | Hyderabad pharma hub | Export and regulatory expertise |
| Maharashtra | Mumbai, Pune, Aurangabad | Large markets and logistics |
| Madhya Pradesh | Pithampur cluster | Export units and land access |
The strongest locations combine an established pharmaceutical ecosystem with good logistics to major markets. Baddi, Gujarat, and Uttarakhand host many formulation and contract manufacturers, while Hyderabad, Maharashtra, and Pithampur offer export experience. Because ORS demand peaks in summer and the monsoon, warehousing and distribution capacity to stock ahead of these seasons is also important.
GMP, Formula Compliance and Quality Requirements
WHO-formula ORS is a medicine, so manufacturing must follow drug regulations and good manufacturing practices under the revised Schedule M, with documented processes, controlled areas, and a quality control laboratory. Each batch must meet the composition specified in the pharmacopoeia and WHO guidance, verified by assay of sodium, potassium, chloride, citrate, and glucose, along with moisture, uniformity, and microbial tests. Blending and packing rooms need low relative humidity, typically maintained by dehumidifiers. Export and donor-funded supply usually requires WHO-GMP certification. Designing the facility around these requirements from the start makes licensing and customer audits far smoother.
Infrastructure Requirements (Sachet Plant)
| Infrastructure Element | Specification | India-Specific Note |
|---|---|---|
| Total Land Area | 3,000 – 8,000 sq. meters | Pharma cluster or industrial plot |
| Low-Humidity Production Area | Dehumidified blending and packing | Critical for powder stability |
| HVAC & Dehumidifiers | Controlled temperature and RH | Core GMP requirement |
| Power Requirement | 300 kW – 1 MW | Packing lines and HVAC |
| QC Laboratory | Assay and microbial testing | Batch release |
| Warehousing | Raw materials and finished goods | Seasonal stock build-up |
| Water System (for RTD) | Purified water generation | Needed for liquid ORS |
Infrastructure for an ORS plant centres on dehumidified production areas, HVAC, a capable QC laboratory, and generous warehousing for seasonal stock. Plants planning ready-to-drink ORS also need purified water systems, liquid processing, and filling lines. Planning space for additional sachet lines or a liquid line from the start makes expansion easier.
The machinery set for a sachet plant is compact and well established, centred on sifting, blending, and high-speed sachet packing, while ready-to-drink production adds liquid processing and filling equipment. The core machinery is summarised below.
| Equipment | Function | Key Specification |
|---|---|---|
| Tray / Fluid Bed Dryer | Condition raw materials | Moisture control |
| Vibro Sifter & Multimill | Size ingredients | Stainless steel, GMP design |
| Weighing & Dispensing Booth | Weigh to formula | Calibrated balances |
| V / Octagonal Blender | Uniform blending | Validated mixing |
| Multi-Track Sachet Machine | Fill and seal sachets | High speed, accurate fill |
| Dehumidifiers & HVAC | Control humidity | Low RH in process areas |
| Inkjet / Laser Coder | Print batch details | Clear, permanent codes |
| Checkweigher & Leak Tester | Verify fill and seal | Inline quality control |
| Cartoning & Kitting Machine | Pack cartons and kits | Automated cartoning |
| RTD Mixing, Sterilising & Filling Line | Produce liquid ORS | Aseptic or hot-fill capability |
Equipment selection should follow your formats and capacity. A sachet plant depends mainly on accurate blending and reliable multi-track packing machines, which set throughput and fill accuracy. Ready-to-drink production requires a substantial additional investment in water treatment, mixing, sterilisation, and filling. Laboratory instruments for assay and moisture testing are essential for every batch release.
The tables below summarise the capital and operating cost structure of an ORS sachet facility in India, based on industry analysis. The total Oral Rehydration Salt (ORS) Investment Cost for a specific project depends on capacity, formats, automation, location, and whether ready-to-drink capability is included.
Capital Expenditure (CapEx) Cost Structure
| CapEx Component | % of Total CapEx | What It Covers |
|---|---|---|
| Plant & Machinery | 35–45% | Blending, sachet packing, cartoning |
| Land, Building & Controlled Areas | 25–35% | Factory and low-humidity zones |
| HVAC & Dehumidification | 8–12% | Environmental control systems |
| QC Laboratory | 5–8% | Testing instruments |
| Pre-operative & Certification | 3–6% | Licensing, validation, DPR |
| Working Capital | 10–15% | Raw materials, packaging, receivables |
Machinery and controlled production areas form the largest share of capital, with HVAC and dehumidification significant because of the powder's sensitivity to moisture. Working capital matters because stock is built ahead of peak seasons and government tenders may involve longer payment cycles. These elements are modelled in detail in an Oral Rehydration Salt (ORS) Business Plan so that format and capacity decisions rest on realistic numbers.
Operating Expenditure (OpEx) Cost Structure
| OpEx Component | % of Total OpEx | India-Specific Note |
|---|---|---|
| Raw Materials | 25–35% | Glucose and salts |
| Packaging Materials | 25–32% | Laminated sachets and cartons |
| Labour & Manpower | 8–12% | Production, QA, and QC staff |
| Power & Utilities | 6–10% | HVAC and dehumidification |
| Marketing & Distribution | 8–12% | Pharmacy and doctor outreach |
| Maintenance & Overheads | 4–7% | Equipment upkeep and administration |
Raw materials and packaging together make up the majority of operating cost, so procurement and packing efficiency drive margins. Branded retail sales carry marketing costs but higher prices, while tender supply has minimal marketing but tight pricing. A sound financial model should test returns against input prices, tender price levels, seasonality, and channel mix.
Based on analysis of a sachet facility, the financial profile is solid, supported by steady essential demand, simple technology, and moderate capital needs. The profitability of Oral Rehydration Salt (ORS) manufacturing business in India improves with high-speed packing, a balance of branded and institutional sales, flavoured and ready-to-drink formats, and WHO-GMP certification for exports.
| Financial Metric | Indicative Value | India Context |
|---|---|---|
| Gross Profit Margin | 35–50% | Higher for branded and flavoured ORS |
| Net Profit Margin | 12–20% | After depreciation and Indian corporate taxes |
| Payback Period | 3–5 Years | Faster with contract volumes |
| IRR (Internal Rate of Return) | 18–25% | Higher with exports and RTD |
| Capacity Utilization (stable ops) | 65–85% | Seasonal peaks in summer and monsoon |
| Break-even Capacity Utilization | 40–50% | Moderate fixed costs |
Channel mix and seasonality are the decisive factors. Public health tenders provide large volumes at low prices, while branded retail and ready-to-drink products earn better margins but require marketing and distribution. Because demand peaks seasonally, production planning, inventory build-up, and flexible staffing are important to keep lines productive through the year.
Returns can be strengthened by securing contract manufacturing agreements with established brands, adding flavoured and ready-to-drink formats, offering ORS and zinc kits for programmes, obtaining WHO-GMP certification for exports, and optimising packaging costs through efficient laminate use and high-speed lines.
Key Risks and Mitigation
The principal risks are price pressure in tenders, seasonal demand swings, competition from established brands, regulatory compliance, and moisture-related quality failures. Price risk is mitigated by efficient operations and a balanced channel mix; seasonality by building stock and serving export markets in different seasons; competitive risk by contract manufacturing and differentiated formats; regulatory risk by strict adherence to the WHO formula and GMP; and quality risk by humidity control and robust packaging. A manufacturer that treats formula compliance, efficiency, and channel diversity as core priorities is best placed to sustain returns.
WHO-formula ORS is regulated as a drug in India, and its labelling is also shaped by food regulators' rules on the use of the term "ORS". Promoters typically need the following before commencing operations:
The drug manufacturing license and GMP readiness sit on the critical path, since ORS cannot be sold without them. Label artwork should be checked carefully against current rules before launch. Engaging an Oral Rehydration Salt (ORS) Manufacturing Consultant in India with pharmaceutical licensing experience helps promoters plan facility design, licensing, and product registration together.
Note: The exact approvals, registrations, licenses, and certification requirements may vary depending on factors such as plant location, formats, target markets, and applicable regulations. Businesses are advised to undertake a detailed regulatory assessment during the project planning stage to ensure full compliance and timely implementation.
Several recent developments shape the outlook for ORS manufacturers in India:
The common thread is a market where genuine, WHO-compliant ORS is gaining ground as regulators and doctors push back against sugary look-alike drinks. For new entrants, the opportunity is to build efficient, GMP-compliant capacity, offer both sachet and convenient formats, and serve retail, institutional, and export customers with products that clearly meet the standard.
A detailed project report and DPR provides a structured roadmap for the facility, covering market demand, format and channel strategy, process design, machinery, plant layout, humidity control, regulatory pathway, and economics. It helps investors decide optimal capacity and formats, estimate capital expenditure (CapEx) and operating expenditure (OpEx), assess profitability, and identify risks before implementation.
The report also includes a detailed Oral Rehydration Salt (ORS) Financial Model with format-wise revenues, raw material and packaging costs, seasonal production planning, cash flow projections, break-even, return on investment (ROI), and payback calculations. These outputs help promoters, lenders, and partners judge long-term viability. Many investors engage an Oral Rehydration Salt (ORS) Plant Project Report Consultant in India or an Oral Rehydration Salt (ORS) Manufacturing Feasibility Study Consultant to prepare and validate these documents for bank appraisal.
For an ORS project specifically, a strong DPR also clarifies the balance between branded, contract, and tender business, the decision on ready-to-drink capability, the WHO-GMP roadmap, and seasonal inventory planning, which are the factors most likely to determine success. By testing returns against tender prices, input costs, and utilisation, the report turns a steady essential-medicine opportunity into a plan that lenders and partners can back with confidence.
How to start an oral rehydration salt (ORS) manufacturing plant in India?
Begin by choosing your formats and channels, then commission a feasibility study and DPR. Secure a site in a pharma cluster, build a revised Schedule M-compliant facility with low-humidity blending and packing areas and a QC laboratory, install sifting, blending, and sachet packing machines, obtain the drug manufacturing license and other approvals, and confirm that your formula and labels meet WHO and FSSAI requirements.
What is the oral rehydration salt (ORS) manufacturing plant setup cost in India?
A powder sachet plant typically needs INR 8 crore to INR 25 crore, while a facility that also produces ready-to-drink ORS can require INR 40 crore to INR 80 crore, depending on capacity and automation.
What is the process for making oral rehydration salt (ORS)?
Pharmacopoeial-grade glucose and salts are tested, conditioned, sifted, and weighed to the WHO formula, blended uniformly, checked for content and moisture, filled into laminated sachets in a low-humidity room, sealed, coded, inspected, cartoned, and released after testing.
What machinery is needed for an oral rehydration salt (ORS) manufacturing plant?
Key equipment includes a dryer, vibro sifter and multimill, weighing booth, V or octagonal blender, multi-track sachet filling and sealing machine, dehumidifiers and HVAC, coder, checkweigher and leak tester, cartoning machine, and, for liquid ORS, mixing, sterilising, and filling equipment.
What raw materials are used to make oral rehydration salt (ORS)?
The WHO formula uses anhydrous glucose, sodium chloride, potassium chloride, and trisodium citrate dihydrate, all of pharmacopoeial grade, along with laminated sachet film and cartons. Flavoured versions add permitted flavours.
Is oral rehydration salt (ORS) manufacturing profitable in India?
A well-run plant typically earns a 12 to 20% net margin and an 18 to 25% IRR, with payback in 3 to 5 years. Returns improve with branded and flavoured products, ready-to-drink formats, contract volumes, and export certification.
What licenses are required for an oral rehydration salt (ORS) manufacturing unit in India?
Key approvals include a drug manufacturing license, revised Schedule M compliance and WHO-GMP certification where needed, formula and labelling compliance, State Pollution Control Board consents, a Factory License, a Fire NOC, and GST, Udyam, Legal Metrology, and labour registrations.
Which state is best for an oral rehydration salt (ORS) manufacturing plant?
Himachal Pradesh, Gujarat, Uttarakhand, Telangana, Maharashtra, and Madhya Pradesh are strong options because of their pharmaceutical ecosystems. The best site depends on access to skilled staff, packaging suppliers, and logistics to your main markets.
How do I get a feasibility study or DPR for an oral rehydration salt (ORS) manufacturing plant?
A professionally prepared DPR covers market assessment, format and channel strategy, technical design, approvals, costs, and financial projections suitable for bank appraisal. Many promoters work with an Oral Rehydration Salt (ORS) Business Plan Consultant in India to prepare it and align it with lender requirements.
Have a question or need assistance?
Please complete the form with your inquiry or reach out to us at
Phone Number
+91-120-433-0800